Filing Flows › Biogen (BIIB) › Operating margin
Biogen (BIIB) operating margin by quarter
Biogen's operating margin was 4.8% in Q2 2026 (second quarter 2026), -10.4 pts from Q1 2026. Over the last 5 quarters it ranged from 4.8% (Q2 2026) to 28.1% (Q2 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 4.8% | -10.4 pts | -23.3 pts |
| Q1 2026 | 15.2% | -6.7 pts | +2.4 pts |
| Q3 2025 | 22.0% | -6.1 pts | — |
| Q2 2025 | 28.1% | +15.3 pts | — |
| Q1 2025 | 12.8% | — | — |
Q2 2026 at a glance
Biogen, Q2 2026: revenue $2.7B (+3% year over year), operating margin 4.8%, net earnings $97.5M, operating cash flow $449M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biogen's operating margin?
Biogen's operating margin was 4.8% in Q2 2026 (second quarter 2026), -10.4 pts from Q1 2026.
How has Biogen's operating margin changed?
Over the last 5 quarters it ranged from 4.8% (Q2 2026) to 28.1% (Q2 2025).